FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:1320-1327 March 25, 2004 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors' clinical recommendations.

A 28-year-old man presents with a two-year history of increasing dyspnea on strenuous exertion and is found to have hypertrophic cardiomyopathy, with a septal thickness of 23 mm and a left ventricular outflow gradient of 80 mm Hg. There is no family history of hypertrophic cardiomyopathy or sudden death. Forty-eight-hour Holter monitoring shows infrequent premature ventricular contractions. How should this patient be . . . [Full Text of this Article]

The Clinical Problem

Strategies and Evidence

Diagnostic Evaluation

Pharmacologic Therapy

Other Interventions

            Surgical Septal Myectomy

            Implantation of a Dual-Chamber Pacemaker

            Alcohol-Induced Septal Ablation

Risk of Sudden Death

Other Complications

Guidelines

Areas of Uncertainty

Conclusions and Recommendations

Source Information

From the Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, where reprint requests should be addressed to Dr. Nishimura.

This article has been cited by other articles:

• Gupta, S., Baman, T., Day, S. M. (2009). Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening. Sports Health: A Multidisciplinary Approach 1: 500-507 [Abstract] [Full Text]  
• Lin, G, Nishimura, R A, Gersh, B J, Phil, D, Ommen, S R, Ackerman, M J, Brady, P A (2009). Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy. Heart 95: 709-714 [Abstract] [Full Text]  
• Spirito, P., Autore, C., Rapezzi, C., Bernabo, P., Badagliacca, R., Maron, M. S., Bongioanni, S., Coccolo, F., Estes, N.A. M., Barilla, C. S., Biagini, E., Quarta, G., Conte, M. R., Bruzzi, P., Maron, B. J. (2009). Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy. Circulation 119: 1703-1710 [Abstract] [Full Text]  
• Jaber, W A, Yang, E H, Nishimura, R A, Sorajja, P, Rihal, C S, Elesber, A, Eeckhout, E, Lerman, A (2009). Immediate improvement in coronary flow reserve after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Heart 95: 564-569 [Abstract] [Full Text]  
• van Dalen, B M, Kauer, F, Soliman, O I I, Vletter, W B, Michels, M, Cate, F J t., Geleijnse, M L (2009). Influence of the pattern of hypertrophy on left ventricular twist in hypertrophic cardiomyopathy. Heart 95: 657-661 [Abstract] [Full Text]  
• Siswanto, B B, Aryani, R (2009). Recent advances in diagnosis and management of hypertrophic cardiomyopathy. Heart Asia 2009: 1-4 [Abstract] [Full Text]  
• Soor, G S, Luk, A, Ahn, E, Abraham, J R, Woo, A, Ralph-Edwards, A, Butany, J (2009). Hypertrophic cardiomyopathy: current understanding and treatment objectives. J. Clin. Pathol. 62: 226-235 [Abstract] [Full Text]  
• Whitten, S. E. (2008). Systolic Heart Failure in a Patient With Hypertrophic Obstructive Cardiomyopathy: A Potentially Life-Threatening Complication. Crit Care Nurse 28: 44-52 [Full Text]  
• Sorajja, P., Nishimura, R. A., Ommen, S. R., Rihal, C. S., Gersh, B. J., Holmes, D. R. Jr (2008). Effect of Septal Ablation on Myocardial Relaxation and Left Atrial Pressure in Hypertrophic Cardiomyopathy: An Invasive Hemodynamic Study. J Am Coll Cardiol Intv 1: 552-560 [Abstract] [Full Text]  
• Kottke, T. E., Solberg, L. I., Nelson, A. F., Belcher, D. W., Caplan, W., Green, L. W., Lydick, E., Magid, D. J., Rolnick, S. J., Woolf, S. H. (2008). Optimizing Practice Through Research: A New Perspective to Solve an Old Problem. Ann Fam Med 6: 459-462 [Abstract] [Full Text]  
• Geske, J. B., Sorajja, P., Nishimura, R. A., Ommen, S. R. (2007). Evaluation of Left Ventricular Filling Pressures by Doppler Echocardiography in Patients With Hypertrophic Cardiomyopathy: Correlation With Direct Left Atrial Pressure Measurement at Cardiac Catheterization. Circulation 116: 2702-2708 [Abstract] [Full Text]  
• ElBardissi, A. W., Dearani, J. A., Nishimura, R. A., Ommen, S. R., Stulak, J. M., Schaff, H. V. (2007). Septal Myectomy After Previous Septal Artery Ablation in Hypertrophic Cardiomyopathy. Mayo Clin Proc. 82: 1516-1522 [Abstract] [Full Text]  
• McLeod, C. J., Ommen, S. R., Ackerman, M. J., Weivoda, P. L., Shen, W. K., Dearani, J. A., Schaff, H. V., Tajik, A. J., Gersh, B. J. (2007). Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy. Eur Heart J 28: 2583-2588 [Abstract] [Full Text]  
• Nishimura, R. A., Ommen, S. R. (2007). Hypertrophic Cardiomyopathy, Sudden Death, and Implantable Cardiac Defibrillators: How Low the Bar?. JAMA 298: 452-454 [Full Text]  
• Maron, B. J. (2007). Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy. Circulation 116: 196-206 [Full Text]  
• Kurisu, S., Inoue, I., Kawagoe, T., Ishihara, M., Shimatani, Y., Nakama, Y., Kagawa, E. (2007). Pressure tracings in obstructive Tako-Tsubo cardiomyopathy. Eur J Heart Fail 9: 317-319 [Abstract] [Full Text]  
• Valeti, U. S., Nishimura, R. A., Holmes, D. R., Araoz, P. A., Glockner, J. F., Breen, J. F., Ommen, S. R., Gersh, B. J., Tajik, A. J., Rihal, C. S., Schaff, H. V., Maron, B. J. (2007). Comparison of Surgical Septal Myectomy and Alcohol Septal Ablation With Cardiac Magnetic Resonance Imaging in Patients With Hypertrophic Obstructive Cardiomyopathy. J Am Coll Cardiol 49: 350-357 [Abstract] [Full Text]  
• Stout, K. K., Otto, C. M. (2007). Indications for Aortic Valve Replacement in Aortic Stenosis. J Intensive Care Med 22: 14-25 [Abstract]  
• Nishimura, R. A., Ommen, S. R. (2006). Hypertrophic Cardiomyopathy: The Search for Obstruction. Circulation 114: 2200-2202 [Full Text]  
• Jassal, D. S., Neilan, T. G., Fifer, M. A., Palacios, I. F., Lowry, P. A., Vlahakes, G. J., Picard, M. H., Yoerger, D. M. (2006). Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Eur Heart J 27: 1805-1810 [Abstract] [Full Text]  
• Spirito, P., Autore, C. (2006). Management of hypertrophic cardiomyopathy.. BMJ 332: 1251-1255 [Full Text]  
• Barbey, F., Brakch, N., Linhart, A., Rosenblatt-Velin, N., Jeanrenaud, X., Qanadli, S., Steinmann, B., Burnier, M., Palecek, T., Bultas, J., Hayoz, D. (2006). Cardiac and Vascular Hypertrophy in Fabry Disease: Evidence for a New Mechanism Independent of Blood Pressure and Glycosphingolipid Deposition. Arterioscler. Thromb. Vasc. Bio. 26: 839-844 [Abstract] [Full Text]  
• Minakata, K., Dearani, J. A., Schaff, H. V., O'Leary, P. W., Ommen, S. R., Danielson, G. K. (2005). Mechanisms for Recurrent Left Ventricular Outflow Tract Obstruction After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy. Ann. Thorac. Surg. 80: 851-856 [Abstract] [Full Text]  
• Binder, W. D., Fifer, M. A., King, M. E., Stone, J. R. (2005). Case 26-2005 - A 48-Year-Old Man with Sudden Loss of Consciousness while Jogging. NEJM 353: 824-832 [Full Text]  
• Ommen, S. R., Maron, B. J., Olivotto, I., Maron, M. S., Cecchi, F., Betocchi, S., Gersh, B. J., Ackerman, M. J., McCully, R. B., Dearani, J. A., Schaff, H. V., Danielson, G. K., Tajik, A. J., Nishimura, R. A. (2005). Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol 46: 470-476 [Abstract] [Full Text]  
• Maron, B. J. (2005). Surgery for Hypertrophic Obstructive Cardiomyopathy: Alive and Quite Well. Circulation 111: 2016-2018 [Full Text]  
• Liu, X., Ouyang, F., Mavrakis, H., Ma, C., Dong, J., Ernst, S., Bänsch, D., Antz, M., Kuck, K.-H. (2005). Complete pulmonary vein isolation guided by three-dimensional electroanatomical mapping for the treatment of paroxysmal atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy. Europace 7: 421-427 [Abstract] [Full Text]  
• Talreja, D. R., Nishimura, R. A., Edwards, W. D., Valeti, U. S., Ommen, S. R., Tajik, A. J., Dearani, J. A., Schaff, H. V., Holmes, D. R. Jr (2004). Alcohol septal ablation versus surgical septal myectomy: Comparison of effects on atrioventricular conduction tissue. J Am Coll Cardiol 44: 2329-2332 [Abstract] [Full Text]  
• Maron, B. J., Dearani, J. A., Ommen, S. R., Maron, M. S., Schaff, H. V., Gersh, B. J., Nishimura, R. A. (2004). The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 44: 2044-2053 [Abstract] [Full Text]